FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2101876148> ?p ?o ?g. }

• W2101876148 endingPage "1837" @default.
• W2101876148 startingPage "1834" @default.
• W2101876148 abstract "Antiphospholipid antibodies are strongly associated with arterial and venous thrombosis and with fetal loss. Recently an experimental model for antiphospholipid syndrome (APLS) was established in our laboratory. In this model, mice are immunized passively or actively with anticardiolipin antibodies and acquire the syndrome, which is characterized by prolonged activated partial thromboplastin time (APTT), thrombocytopenia, low fecundity rate, and fetal loss. In a normal process of pregnancy, lymphokines affect fetal implantation and development. Cytokines from the colony stimulating factor family, like GM-CSF and IL-3, were shown to be positive signals for implantation and to promote placental development and fetal growth. Given our preliminary findings of low IL-3 in mice with APLS and the efficacy of IL-3 in preventing fetal loss in a strain of mice prone to fetal resorption, our aim in the present study was to examine the effect of murine recombinant IL-3 (mrIL-3) on pregnant mice induced with experimental APLS. Mice were passively transfused to the tail vein, 24 h following mating, with anticardiolipin antibodies. The mice were divided into two groups: one group was injected intraperitoneally with mrIL-3 on days 6.5, 8.5, and 10.5 after mating, while the control group was injected with PBS. When the mice were killed on day 15 of pregnancy a 32% +/- 4.2 resorption rate was observed in the anti-cardiolipin-immunized group, which was reduced to 4% +/- 0.3 following treatment with mrIL-3. The thrombocytopenia associated with the experimental APLS was also corrected following lymphokine administration. IL-3 may be effective in prevention of recurrent fetal loss in APLS." @default.
• W2101876148 created "2016-06-24" @default.
• W2101876148 creator A5011264921 @default.
• W2101876148 creator A5018711659 @default.
• W2101876148 creator A5023006840 @default.
• W2101876148 creator A5028465552 @default.
• W2101876148 creator A5032586734 @default.
• W2101876148 creator A5074738902 @default.
• W2101876148 creator A5091131982 @default.
• W2101876148 date "1993-04-01" @default.
• W2101876148 modified "2023-10-01" @default.
• W2101876148 title "Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3." @default.
• W2101876148 cites W1526539212 @default.
• W2101876148 cites W1825082566 @default.
• W2101876148 cites W1970668556 @default.
• W2101876148 cites W1987095481 @default.
• W2101876148 cites W1990994815 @default.
• W2101876148 cites W2026836398 @default.
• W2101876148 cites W2036471887 @default.
• W2101876148 cites W2056911426 @default.
• W2101876148 cites W2070695546 @default.
• W2101876148 cites W2074332508 @default.
• W2101876148 cites W2076733817 @default.
• W2101876148 cites W2104538381 @default.
• W2101876148 cites W2109656144 @default.
• W2101876148 cites W2119837316 @default.
• W2101876148 cites W2122820294 @default.
• W2101876148 cites W2253716135 @default.
• W2101876148 cites W2261504327 @default.
• W2101876148 cites W2396444855 @default.
• W2101876148 cites W2407906249 @default.
• W2101876148 cites W2409704987 @default.
• W2101876148 cites W2413103043 @default.
• W2101876148 cites W2416498179 @default.
• W2101876148 cites W2419306110 @default.
• W2101876148 cites W2428941029 @default.
• W2101876148 cites W286602416 @default.
• W2101876148 doi "https://doi.org/10.1172/jci116396" @default.
• W2101876148 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/288166" @default.
• W2101876148 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8473523" @default.
• W2101876148 hasPublicationYear "1993" @default.
• W2101876148 type Work @default.
• W2101876148 sameAs 2101876148 @default.
• W2101876148 citedByCount "130" @default.
• W2101876148 countsByYear W21018761482012 @default.
• W2101876148 countsByYear W21018761482013 @default.
• W2101876148 countsByYear W21018761482014 @default.
• W2101876148 countsByYear W21018761482017 @default.
• W2101876148 countsByYear W21018761482018 @default.
• W2101876148 countsByYear W21018761482019 @default.
• W2101876148 countsByYear W21018761482020 @default.
• W2101876148 countsByYear W21018761482021 @default.
• W2101876148 countsByYear W21018761482022 @default.
• W2101876148 countsByYear W21018761482023 @default.
• W2101876148 crossrefType "journal-article" @default.
• W2101876148 hasAuthorship W2101876148A5011264921 @default.
• W2101876148 hasAuthorship W2101876148A5018711659 @default.
• W2101876148 hasAuthorship W2101876148A5023006840 @default.
• W2101876148 hasAuthorship W2101876148A5028465552 @default.
• W2101876148 hasAuthorship W2101876148A5032586734 @default.
• W2101876148 hasAuthorship W2101876148A5074738902 @default.
• W2101876148 hasAuthorship W2101876148A5091131982 @default.
• W2101876148 hasBestOaLocation W21018761481 @default.
• W2101876148 hasConcept C126322002 @default.
• W2101876148 hasConcept C134018914 @default.
• W2101876148 hasConcept C144594695 @default.
• W2101876148 hasConcept C147483822 @default.
• W2101876148 hasConcept C159654299 @default.
• W2101876148 hasConcept C16685009 @default.
• W2101876148 hasConcept C172680121 @default.
• W2101876148 hasConcept C203014093 @default.
• W2101876148 hasConcept C2776874634 @default.
• W2101876148 hasConcept C2778261982 @default.
• W2101876148 hasConcept C2778382381 @default.
• W2101876148 hasConcept C2779234561 @default.
• W2101876148 hasConcept C49382859 @default.
• W2101876148 hasConcept C54355233 @default.
• W2101876148 hasConcept C71924100 @default.
• W2101876148 hasConcept C86803240 @default.
• W2101876148 hasConceptScore W2101876148C126322002 @default.
• W2101876148 hasConceptScore W2101876148C134018914 @default.
• W2101876148 hasConceptScore W2101876148C144594695 @default.
• W2101876148 hasConceptScore W2101876148C147483822 @default.
• W2101876148 hasConceptScore W2101876148C159654299 @default.
• W2101876148 hasConceptScore W2101876148C16685009 @default.
• W2101876148 hasConceptScore W2101876148C172680121 @default.
• W2101876148 hasConceptScore W2101876148C203014093 @default.
• W2101876148 hasConceptScore W2101876148C2776874634 @default.
• W2101876148 hasConceptScore W2101876148C2778261982 @default.
• W2101876148 hasConceptScore W2101876148C2778382381 @default.
• W2101876148 hasConceptScore W2101876148C2779234561 @default.
• W2101876148 hasConceptScore W2101876148C49382859 @default.
• W2101876148 hasConceptScore W2101876148C54355233 @default.
• W2101876148 hasConceptScore W2101876148C71924100 @default.
• W2101876148 hasConceptScore W2101876148C86803240 @default.
• W2101876148 hasIssue "4" @default.
• W2101876148 hasLocation W21018761481 @default.
• W2101876148 hasLocation W21018761482 @default.

• next